Operating income increased 19.1%
Operating income changed +19.1% from the comparable as-filed period.
$6.8M→$8.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IRMD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue moved 483 bp lower
Capex / revenue changed -483 basis points from the comparable as-filed period.
5.37%→0.54%2 prior comparisons
Gross margin moved 410 bp lower
Gross margin changed -410 basis points from the comparable as-filed period.
78.17%→74.07%2 prior comparisons
Inventory / revenue moved 501 bp higher
Inventory / revenue changed +501 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
54.88%→59.89%2 prior comparisons
Capital expenditure decreased 93.0%
Capital expenditure changed -93.0% from the comparable as-filed period.
$2.6M→$185,0003 prior comparisons
Capex / revenue moved 1201 bp lower
Capex / revenue changed -1201 basis points from the comparable as-filed period.
12.91%→0.90%2 prior comparisons
Operating cash flow decreased 23.3%
Operating cash flow changed -23.3% from the comparable as-filed period.
$7.7M→$5.9M3 prior comparisons
Operating margin moved 203 bp lower
Operating margin changed -203 basis points from the comparable as-filed period.
33.26%→31.23%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.